Neurofibromatosis (NF) Center

Medicine & Life Sciences

1. Arnold-Chiari Malformation 9%
2. Astrocytes 18%
3. Astrocytoma 22%
4. Autism Spectrum Disorder 29%
5. Autistic Disorder 27%
6. Biomarkers 7%
7. Brain 29%
8. Brain Injuries 5%
9. Brain Neoplasms 20%
10. Breast Neoplasms 9%
11. Central Nervous System 7%
12. Central Nervous System Neoplasms 6%
13. Cerebral Infarction 6%
14. Cerebrospinal Fluid 11%
15. Cerebrospinal Fluid Shunts 6%
16. Child 36%
17. Circulating Tumor DNA 7%
18. Clinical Trials 9%
19. Confidence Intervals 6%
20. Datasets 6%
21. Decompression 5%
22. Diffusion Tensor Imaging 8%
23. Drug Therapy 6%
24. Electronic Health Records 10%
25. Ependymoma 5%
26. Epilepsy 7%
27. Geminin 8%
28. Gene Expression 7%
29. Genes 15%
30. Glioblastoma 13%
31. Glioma 32%
32. Growth 17%
33. Health 6%
34. Hydrocephalus 29%
35. Informatics 11%
36. Learning 5%
37. Machine Learning 5%
38. Magnetic Resonance Imaging 14%
39. Meningioma 14%
40. Microglia 9%
41. MicroRNAs 6%
42. Mutation 18%
43. Neoplasms 40%
44. Nervous System Neoplasms 6%
45. Neurilemmoma 5%
46. Neurodevelopmental Disorders 7%
47. Neurofibroma 6%
48. Neurofibromatoses 13%
49. Neurofibromatosis 1 100%
50. Neurofibromatosis 1 Genes 18%
51. Neurofibromatosis 2 19%
52. Neurofibromin 1 30%
53. Neurofibromin 2 21%
54. Neurofibrosarcoma 20%
55. Neuroglia 8%
56. Neuroimaging 5%
57. Neurons 11%
58. Optic Nerve Glioma 28%
59. Pediatrics 31%
60. Phenotype 8%
61. Plexiform Neurofibroma 8%
62. Population 9%
63. Progression-Free Survival 5%
64. Proteins 10%
65. Recurrence 8%
66. RNA Sequence Analysis 5%
67. Sarcoma 8%
68. Schwann Cells 5%
69. Seizures 7%
70. Siblings 5%
71. Sickle Cell Anemia 10%
72. Stem Cells 5%
73. Stroke 7%
74. Survival 11%
75. Syringomyelia 6%
76. Therapeutics 15%
77. TOR Serine-Threonine Kinases 5%
78. Translational Medical Research 5%
79. Tuberous Sclerosis 10%
80. Tumor Suppressor Genes 7%
81. Twins 5%
82. Ventriculostomy 6%
83. White Matter 14%
84. Workflow 5%
85. Wounds and Injuries 7%